The BMI calculator does not determine eligibility for weight loss medications
Factors such as previous eye problems, cardiovascular disease, and use of other medications known to increase NAION risk (like PDE5 inhibitors) should be carefully evaluated before starting GLP-1 therapy
Click the button below to learn how you can sponsor the next edition of Big Pharma Sharma
igoriss/iStock/Getty Images Plus Changing Tastes While there is now good consensus on what GLP-1 users should be eating, Maha Tahiri, CEO and founder of Nutrition Sustainability Strategies LLC, who has taken a GLP-1 agonist herself, says it isnt always easy for users to actually get the nutrition they need
Cannula placement was checked by inspecting post-mortem thionin-stained brain sections under a low-power microscope
A 26-week randomized controlled trial of semaglutide once daily versus liraglutide and placebo in patients with type 2 diabetes suboptimally controlled on diet and exercise with or without metformin